Assertio Holdings announced the appointment of Howard J. Franklin, MD, as Senior Vice President, Medical. Dr. Franklin was previously Chief Medical Officer at Finch Therapeutics
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on ASRT:
- Assertio Appoints Dr. Howard Franklin as Senior Vice President, Medical
- Assertio Holdings price target raised to $8 from $6 at BWS Financial
- Assertio Holdings announces exchange offer of $30M of senior notes
- Assertio Announces Exchange Offer of $30 Million of its Currently Outstanding 6.50% Convertible Senior Notes Due 2027
- Assertio Holdings sees 2022 adjusted EPS $1.18-$1.19, consensus 64c
